AI-powered search
Try Polaris, our new AI-powered search!

What factors should be considered when determining if a patient is eligible for ruxolitinib for vitiligo?

Featuring Cheri Frey, MD |

Assistant Professor, Dermatology & Residency Program Director 
Director of Cosmetic Dermatology
Howard University
Washington, DC

| Published June 01, 2024